Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis

Elif Kabasakal

Status: Completed

Conditions: Cystic Fibrosis

Treatments: Behavioral: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form

Study type: Observational

Funder types: Other

Identifiers

NCT05195216

MedipolU-KABASAKAL-001

Details and patient eligibility

About

The purpose of this study; The COVID-19 pandemic is to investigate the effects of COVID-19 fear levels of patients with cystic fibrosis on the psychosocial and quality of life levels of individuals.

Full description

After individuals were informed about the study, it was administered to individuals who gave written informed consent.This study was carried out on individuals with cystic fibrosis and healthy individuals who meet the eligibility requirements, through online forms.

Enrollment: 128 patients

Sex: All

Ages: 16+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• be 16 years of age or older
• Having been diagnosed with Cystic Fibrosis
• Volunteering to participate in the research

Exclusion criteria

• Being mentally incapable of successfully applying the scales to be applied for evaluation purposes
• Being treated with sedative and antiepileptic drugs
• Pregnancy

Trial design

128 participants in 2 patient groups

individuals with cystic fibrosis

Treatment:

Behavioral: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form

healthy individuals

Treatment:

Behavioral: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form